Keynote: Genentech, San Francisco : The Acceleration of Personalized Medicine in the Era of Exponential Genomics

This event was for 550 executives from this pharma-tech company — it’s owned by French pharmaceutical giant Roche. It’s also one of the global leaders in the business of pharmacogenetics : that is, the development of highly targeted drug therapies based on particular genetic profiles.

My keynote took a look at the future of healthcare and the big transformative opportunities that exist in a world of accelerated science. The topic strikes close to home for me : I’ve had my own genetic profile done (the news is all good!)